Intervention
Peripheral Blood Stem Cell Transplantation
ClinicalTrials.gov intervention label
Advertisement
Clinical trials
6 shownGene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell TransplantNCT02797470 · 2016-06-23
ACTIVE_NOT_RECRUITINGScleroderma Treatment With Autologous Transplant (STAT) StudyNCT01413100 · 2011-09-15
COMPLETEDAutologous Stem Cell Transplant for Neurologic Autoimmune DiseasesNCT00716066 · 2008-06-01
ACTIVE_NOT_RECRUITINGBlood Stem Cell Transplant in Treating Patients With Hematologic CancerNCT00008216 · 1996-07-01
TERMINATEDFilgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast CancerNCT00002836 · 1995-09-26
COMPLETEDHigh-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast CancerNCT00002837 · 1995-09-01
COMPLETEDCommon conditions
Breast Cancer2Adult Langerhans Cell Histiocytosis1Autoimmune Disease1Autoimmune Nervous System Disorder1Autologous Transplant Autoimmune1Central Nervous System Vasculitis1Cerebellar Degeneration1Childhood Langerhans Cell Histiocytosis1Chronic Inflammatory Demyelinating Polyneuropathy1CIDP Transplant1HCT for Neurologic Autoimmune Disorders1HIV Infection1Lambert Eaton Myasthenic Syndrome1Leukemia1Lymphoma1Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma1MS Stem Cell Transplant1Multiple Myeloma and Plasma Cell Neoplasm1Multiple Sclerosis Stem Cell Transplant1Multiple Sclerosis Transplant1Myasthenia Gravis1Myasthenia Gravis Transplant1Myelodysplastic Syndromes1Myelodysplastic/Myeloproliferative Neoplasms1Neurologic Autoimmune Disease1
Leading sponsors
Trial status mix
COMPLETED3
ACTIVE_NOT_RECRUITING2
TERMINATED1
Phase mix
PHASE24
PHASE12
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.